Document is current
Any future updates will be listed below
-
Authors
Del Re, M.
Conteduca, V. https://orcid.org/0000-0002-6921-714X
Crucitta, S.
Gurioli, G.
Casadei, C. https://orcid.org/0000-0003-2467-749X
Restante, G.
Schepisi, G.
Lolli, C.
Cucchiara, F. https://orcid.org/0000-0002-0946-750X
Danesi, R. https://orcid.org/0000-0002-4414-8934
De Giorgi, U.
- License Information
-
More Information
Article History
Received: 18 August 2020
Revised: 6 November 2020
Accepted: 4 December 2020
First Online: 26 January 2021
Compliance with ethical standards
:
: MDR received speaker honoraria from Astellas, Astra Zeneca, Celgene, Novartis, Pfizer, Bio-Rad Janssen-Cilag, Sanofi-Aventis; consulting fee from Ipsen and Janssen-Cilag; Speaker’s bureau: Celgene, Janssen, Sanofi; travel support from Janssen, Bio-Rad. VC has received speaker honoraria or travel support from Astellas, Janssen-Cilag, and Sanofi-Aventis, and has received consulting fee from Bayer. RD received honoraria for scientific advisory board and consulting relationship from Ipsen, Novartis, Pfizer, Sanofi Genzyme, AstraZeneca, Janssen, Gilead, Lilly, Gilead, EUSA Pharma; travel support from Ipsen, Sanofi Genzyme. UDG received honoraria as consulting or advisory role for Pfizer, Janssen, Astellas Pharma, Sanofi, Bristol-Myers Squibb, Bayer, Ipsen, Merck; received institutional research funding from Sanofi, AstraZeneca, Roche; received travel support from Bristol-Myers Squibb, Ipsen, Janssen, Pfizer. All remaining authors have declared no conflicts of interest.
: The study was approved by the local Ethics Committees and conducted in accordance with the principles of the Declaration of Helsinki.
: All patients gave their signed informed consent before blood collection and data analysis.
